Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Semin Respir Crit Care Med. 2016 Mar 14;37(2):277–288. doi: 10.1055/s-0036-1578801

Table 2.

Key points for pulmonary specialists caring for HIV-positive persons

  • HIV appears to increase risk of COPD and may accelerate FEV1 decline

  • Diffusion abnormalities are common in HIV, but nonspecific

  • Asthma risk in HIV is unclear

  • Smoking cessation therapies are effective in HIV-infected individuals

  • Consider use of beclomethasone as first-line inhaled corticosteroids in those treated with ritonavir or cobicistat-containing antiretroviral regimens (due to risk of Cushing syndrome)

Abbreviations: COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 second.